Abstract
A premature infant of 31 weeks’ gestation underwent repair of an oesophageal atresia, distal tracheo-oesophageal fistula and anal stenosis. A lymphatic leak was noted at the time of surgery. Chylous drainage persisted and an intravenous infusion of somatostatin was begun. The volume of chyle drained fell dramatically within the first 24 h and was negligible by the 5th day of treatment. No reaccumulation of the chylothorax was seen after the cessation of somatostatin. To our knowledge this is the youngest reported child in whom somatostatin has been used successfully in treating a postoperative chylothorax.
This is a preview of subscription content, log in via an institution to check access.
References
Buettiker V, Hug M, Burger, et al. (2001) Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 27:1083–1086
Al-Zubairy SA, Al-Jazairi AS (2003) Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 37:679–682
Rimensberger PC, Muller-Schenker B, Kalangos A, et al. (1998) Treatment of persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 66:253–254
Pettitt TW, Caspi J, Borne A (2002) Treatment of persistent chylothorax after Norwood procedure with somatostatin. Ann Thorac Surg 72:977–979
Pratap U, Slavik Z, Ofoe V, et al. (2001) Octreotide to treat postoperative chylothorax after cardiac operations ion children. Ann Thorac Surg 72:1740–1742
Cheung Y, Leung M, Yip M (2001) Octreotide for the treatment of postoperative chylothorax. J Pediatr 139:157–159
Bond SJ, Guzzetta PC, Snyder ML, et al. (1993) Management of pediatric postoperative chylothorax. Ann Thorac Surg 56:469–473
Au M, Weber TR, Fleming RE (2003) Successful use of somatostatin in a case of neonatal chylothorax. J Pediatr Surg 38:1106–1107
Goyal A, Smith NP, Jesudason EC, et al. (2003) Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia. J Pediatr Surg 38:E19–E20
Allen E, Van Heekeren D, Spector M, et al. (1991) Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg 26:1169–1174
Ferguson MK, Little AG, Skinner DB (1985) Current concepts in the management of postoperative chylothorax. Ann Thorac Surg 40:542–545
Goto M, Kawamata K, Kitano M, et al. (2003) Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 23:563–564
Kahn CR, Shecter Y (2001) Insulin, oral hypoglycaemic agents and the pharmacology of the pancreas. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman’s: the pharmacological basis of therapeutics, 10th edn. McGraw Hill, New York
Cirera I, Feu F, Garcia-Pagan JC, et al. (1995) Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology 22:106–111
Grosman I, Simon D (1990) Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 85:1061–1072
Nakabayashi H, Sagara H, Usukara N, et al. (1981) Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomised dogs. Diabetes 30:440–445
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clarke, S.A., Lakhoo, K. & Sherwood, W. Somatostatin for intractable postoperative chylothorax in a premature infant. Ped Surgery Int 21, 390–391 (2005). https://doi.org/10.1007/s00383-004-1361-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-004-1361-x